▲ The AccE Glass-Free Detector offers a more comfortable imaging experience due to its lightweight design, which lessens user fatigue without compromising image quality.

To optimize work efficiency and portability, Samsung has introduced a new flagship detector, the AccE Glass-Free Detector. The AccE Glass-Free Detector recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use in the USA.

“Being at the forefront of advancing healthcare imaging, we have recognized the need for new solutions that enhance both patient and user comfortability,” said David Legg, Vice President, Head of Boston Imaging. “From the ER to the OR, our Glass-Free Detector exhibits reliability in versatile environments to help get the job done — and done well.”

The AccE Glass-Free Detector was designed to deliver high-resolution images of a digital detector, while offering exceptional user and patient benefits, including:

The AccE Glass-Free Detector was designed to deliver high-resolution images of a digital detector, while offering exceptional user and patient benefits, including:

• Lightweight Design: Weighs approximately 4.5 pounds,¹ which is 27 percent lighter than the conventional model.²
• Clear Visibility: Exhibits a 76% DQE, leading the market in glassless panel technology.
• Functionality: Features a non-glass flexible panel with center-engraving to position a patient, a side chamfer to ease lifting and a rear grip to support transportation.
• High Load Allowance: Holds up to 881 pounds of surface load and 441 pounds of patient load.³
• Dust and Water Resistant: Enables users to employ the detector with confidence in fast-paced environments.

Samsung persistently works to help professionals by developing best-in-class imaging technology that optimizes functionality. The AccE Glass-Free Detector can be used on the AccE GM85 mobile Digital Radiography system and is coming soon to the AccE GC85A.

To learn more about the AccE Glass-Free Detector, please visit here.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing, clinical, service and commercialization of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

¹ Measured without battery set

² Compared to S4335-AW

³ Based on 40 mm diameter disc at the center

“Samsung is continuing its commitment to deliver meaningful innovation in medical imaging, responding to customers’ ever complex healthcare needs,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We plan to continue our rapid pace of new innovation for the radiology market by leveraging our industry leading Image and Signal Processing and AI advances.”

On display at Samsung’s booth during the event are the following technologies:

Ultrasound System

RS85 Prestige¹, the evolution of the RS85, comes with new imaging Architecture and value added features.

RS85 Prestige

Imaging Architecture

• Crystal Architecture – an imaging architecture that combines CrystalBeam beamformer and CrystalPure imaging engine, combined with the S-Vue Transducer which provides crystal clear images.
• CrystalBeam – a new beamforming technology which delivers high-quality image resolution and increased uniformity of images.
• CrystalPure – Samsung’s latest ultrasound imaging engine with enhanced 2D image processing and color signal processing, offering outstanding image performance and efficient workflow in complex cases.

Value Added Features

• MV-Flow with LumiFlow – offers a detailed view of blood flow in relation to the surrounding tissues with enhanced spatial and temporal resolutions and provides three-dimensional visualization with continuous and 3D-like vascular images.
• ShadowHDR – provides a shadow suppressed image, which is especially useful in capturing highly attenuated regions behind bony structures.
• PureVision – an image processing function that produces clear images with uniformity by performing Speckle Noise Suppression and Edge Enhancement on B-mode.

Digital Radiography

Samsung is showcasing its premium ceiling X-ray GC85A and mobile X-ray GM85 which have been granted ATO (Authorization To Operate) for the Risk Management Framework (RMF) program set forth by the United States Department of Defense (DOD) for high level of cybersecurity regulations, while also exhibiting its new detector line-up with enhanced usability.

GM85

• S-Vue – provides high quality images for diagnostic accuracy and confidence. The S-Vue imaging engine’s adaptive filtering and processing technologies reduce X-ray radiation dose for pediatric patients without compromising the image quality. The dose level can be reduced up to 45% for pediatric abdomen, 15.5% for pediatric chest, and 27% for pediatric skull exams with the new S-Vue engine.
• Auto Lung Nodule Detection²– an AI-based CAD (computer-aided detection) software used to identify and detect lung nodules. It is designed to aid the physician in reviewing chest PA radiographs of adults. The new ALND feature is currently available for sale in Europe (CE marked) and Korea.
• SMART Center – an enterprise-level quality asset monitoring solution which aggregates data from multiple Samsung Digital Radiography devices into one easy-to-use platform. Users can reduce downtime and unnecessary tasks by having centralized control over the DR systems.

Computed Tomography

Samsung is highlighting additional mobile computed tomography (mCT) clinical cases demonstrating reduced response time by the medical team during emergencies, such as stroke, improving patient outcomes.

Featured at RSNA are BodyTom^® Elite and OmniTom^® – mobile whole-body and head CT. These mCTs can be used at the point of care, whenever imaging is needed to determine ideal treatment strategy for the patient – without restrictions of physical space and power. Samsung’s NeuroLogica mCT devices are routinely used by leading institutions in intensive care units, emergency rooms, orthopedic and neurosurgery rooms, brachytherapy suites and ambulances. In addition, Samsung Neurologica, in partnership with Winnebago, will be displaying a mobile lung screening vehicle, which will make this technology more accessible in remote areas.

OmniTom®

Lastly, Samsung will display a Photon Counting Detector (PCD)³ – cutting-edge technology that measures photons emitted by X-rays. PCD, currently under development, has the potential to allow for dose optimization allowing the user to reduce the exposure while maintaining image quality, or increase the image quality by keeping dose equivalence compared to currently used CT detectors. In addition, it should deliver increased data mining capabilities from multiple-energy binning and contribute to the improved utility and effectiveness of AI applications.

Visitors can experience Samsung’s differentiated diagnostic assistive functions and solutions directly at booth #4783 (South Building, Hall A).

Additionally, the attendees can also find a separate ‘AI zone’ that allows visitors to experience Samsung’s latest AI technology.

For more information on Samsung’s healthcare business, and products, please visit https://www.samsunghealthcare.com.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

¹ RS85 Prestige is 510(k) pending and not available for sale in USA.

² ALND is not for sale in the United States.

³ Product is under development and not available for sale in USA or any region of the world.

At booth #506 (Expo. X5), Samsung is displaying medical equipment based on its ‘AccE’ (Access, Accuracy and Efficiency) strategy, which aims to change the industry by incorporating innovations in physical access to provide care wherever needed. Samsung also seeks to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“Samsung is committed to medical advancements for both diagnostic solutions and patient care. We will continue to develop optimized medical equipment to healthcare providers by combining our key values in the pursuit of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison.

Within ultrasound systems, Samsung has made great achievements in Obstetrics and Gynecology and will continue to expand its portfolio to the radiology segment. At ECR 2018, Samsung will present upgraded ultrasound systems including:

• RS85, Samsung’s advanced premium ultrasound system for radiology that provides enhanced image quality and convenience for medical and radiology professionals. The RS85 features MV-Flow technology, which detects blood flow in the microvascular, and S-Shearwave Imaging, which provides new indicators for clinical diagnosis by quantifying the elasticity of tissue. The S-Fusion function extends analysis from the abdomen to the prostate, and also allows coordination and simultaneous comparative analysis of images from other modalities such as MRI and CT for easy and fast biopsy.

• HS70A with Prime, the high-end ultrasound system specifically designed to fit into a general ultrasound imaging setting from routine to complex. It features Arterial Analysis, which detects changes in vessels, providing measurement values such as stiffness. The S-Shearwave and Realistic Vue are additional features that improve image quality.

Samsung will also introduce digital radiography solutions that manage the dose for patients and meet the needs of healthcare providers, including:

• GC85A, which provides outstanding images that boost diagnostic confidence equipped with technologies such as S-Detector and S-Align. The device adopts Low Dose technology for enhanced patient safety. Samsung recently cleared in the U.S. FDA for 50% dose reduction in adults’ chest exams, using GC85A with the new imaging engine S-Vue3.02.

• GM85, a lighter version of original GM85 will be displayed. The weight is reduced, but the functional benefits such as enhanced mobility and streamlined workflow are still retained. GM85 provides advanced patient care through leading edge imaging functions.

At the Beyond Experience Zone, visitors can learn about Samsung’s efforts in supporting radiologists in their diagnoses through various software technologies such as SimGrid^TM, Bone Suppression and Dose Reduction. In addition to superb medical equipment, healthcare providers can visit the Low Dose Campaign Zone and experience how low the radiation dose of GC85A is compared to real life radiation through the Low Dose Quiz.

Samsung Electronics’ subsidiary NeuroLogica will showcase innovative mobile CT OmniTom^®, which features an array of improvements from Samsung’s award-winning CereTom^® CT scanner. OmniTom^® is ideal for cranial procedures and is designed to deliver high-quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients. Samsung will also show its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology.

Samsung is also presenting a prototype of Extremity MRI, which is expected to be a game changer in the industry. It is designed to improve not only cost and space efficiency but also patient convenience, as it reduces the need for the whole body to be in the MRI device to scan extremity areas such as arms and legs.

In addition to showcasing its portfolio of comprehensive healthcare solutions, Samsung will be hosting two satellite symposia throughout the week at ECR. Samsung’s symposia will highlight the key trends and issues across ultrasound imaging and digital radiography technologies.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com/.

Bright sunflowers were part of the ‘dose less, care more’ campaign at the show. The flowers were a natural choice for the initiative because of their ability to take up high concentrations of radioactive elements and toxins into their tissues. They therefore purify soils of contaminants. This illustration signified the ability of Samsung’s new x-ray machine to emit lower levels of radiation.

Reducing the amount of radiation is always the goal for radiologists. Although we’re exposed to low levels of radiation in everyday life from many sources – even the air we breathe – no one wants to expose patients to more radiation than is necessary. The Samsung GC85A premium digital x-ray is a welcome addition to hospitals then, as it emits half as much radiation – which is a huge breakthrough.

The S-Vue engine in the GC85A recently received approval from the US Food and Drug Administration (FDA). The FDA is the US regulator of medical treatments and its approval is the gateway for Samsung’s new x-ray to be rolled out across the country.

Making the GC85A so unique is the spatially adaptive multi-scale processing and advanced de-noising technology that enable high quality images even at half the dose. The technique was tested in a study by Professor Semin Chong from Chung-Ang University. He carried out what’s known in the industry as a phantom test whereby a model based on the human body is used to test the effects of x-ray technology without having to use to a real human. The image processing did indeed produce an equivalent image evaluation score when the dosage was halved.

In practice, patients who receive a chest x-ray from the GC85A are subjected to 8 microsieverts (μSv) of radiation. That’s the same radiation from eating 80 bananas. It’s also as low as the average effective dose absorbed into the body during a three-hour flight from Chicago to New York. In other words, the radiation levels of the Samsung GC85A are low and protect patients from higher levels of radiation that other machines emit.

“We are pleased with the approval of the US FDA,” said Insuk Song, Vice President of Health & Medical Equipment Business at Samsung Electronics. “We plan to expand dose reduction x-rays for other parts of the body such as the abdomen and limbs and infants in the future. We will also continue our efforts to reduce radiation.”